Sickle cell: NICE approves voxelotor after initially rejecting it over
uncertain evidence
-
Up to 4000 patients could be offered voxelotor (Oxbryta), a treatment for
sickle cell disease which may reduce the need for blood transfusions, after
the d...
Há uma hora